Bellocchio v. Garland

CourtDistrict Court, S.D. New York
DecidedJuly 12, 2022
Docket1:21-cv-03280
StatusUnknown

This text of Bellocchio v. Garland (Bellocchio v. Garland) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bellocchio v. Garland, (S.D.N.Y. 2022).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK JOHN BELLOCCHIO, Plaintiff, 21 Civ. 3280 (KPF) -v.- OPINION AND ORDER MERRICK GARLAND, Defendant. KATHERINE POLK FAILLA, District Judge: Plaintiff John Bellocchio brings this action against Defendant Merrick Garland, Attorney General of the United States, in his official capacity, alleging violations of Plaintiff’s rights under the United States Constitution. Specifically, Plaintiff claims that the federal ban on the sale and purchase of human organs restricts his freedom of contract and his right to privacy in violation of the Fifth and Fourteenth Amendments. Defendant now moves for dismissal of Plaintiff’s complaint pursuant to Federal Rules of Civil Procedure 12(b)(1), 12(b)(3), and 12(b)(6). For the reasons set forth in the remainder of this Opinion, the Court finds that Plaintiff lacks standing to bring his claims and grants Defendant’s motion to dismiss. BACKGROUND1 A. Factual Background Plaintiff resides in Oakland, New Jersey, and works as a professional academic. (Compl. ¶¶ 4-5). For approximately three years, Plaintiff has also

1 This Opinion draws its facts from the Complaint (“Compl.” (Dkt. #1)), the well-pleaded allegations of which are taken as true for the purposes of this Opinion. For ease of reference, the Court refers to Defendant’s memorandum of law in support of the motion worked as the owner of Fetch and More, a small business comprised of behaviorists who provide service dogs to veterans and other people in need of them. (Id. at ¶ 6). Plaintiff alleges that he became interested in the concept of

selling his organs after he encountered financial difficulties, and that he was “shocked” when his research uncovered that the purchase and sale of human organs was prohibited by the National Organ Transplant Act of 1984 (“NOTA”), Pub. L. 98-507, 98 Stat. 2339. (Id. at ¶¶ 11, 23-24). To verify his research, Plaintiff called a “major medical center” located within the Southern District of New York, where an employee confirmed that Plaintiff could legally donate his organs, but could not legally sell them. (Id. at ¶¶ 25-26). Plaintiff now challenges the constitutionality of the NOTA provision

prohibiting the sale and purchase of human organs, 42 U.S.C. § 274e (the “NOTA Ban”), which provision states, in relevant part, that “it shall be unlawful for any person to knowingly acquire, receive, or otherwise transfer any human organ for valuable consideration for use in human transplantation if the transfer affects interstate commerce.” 42 U.S.C. § 274e(a). Violations of the NOTA Ban are punishable by a maximum fine of $50,000, a maximum term of imprisonment of five years, or both. Id. § 274e(b).

to dismiss as “Def. Br.” (Dkt. #18); to Plaintiff’s memorandum of law in opposition to the motion to dismiss as “Pl. Opp.” (Dkt. #19); and to Defendant’s reply memorandum of law in support of the motion to dismiss as “Def. Reply” (Dkt. #20). As Plaintiff’s opposition brief did not include numbered pages, citations to that brief refer to the page numbers provided by the ECF filing system. In his Complaint, Plaintiff alleges that nearly 114,000 people in the United States are currently on a waiting list for a lifesaving organ transplant, and that 20 people die each day from the lack of available organs. (Compl.

¶¶ 13-14 (internal citations omitted)). Plaintiff claims that more individuals would receive lifesaving organ transplants if healthy individuals were given a financial incentive to sell their organs. (Id. at ¶¶ 20-21). Plaintiff alleges that the NOTA Ban violates his freedom of contract as protected by the Contract Clause (Compl. ¶¶ 28-33), as well as his right to privacy under the Due Process Clause (id. at ¶¶ 43-54).2 Plaintiff asks this Court to strike down the NOTA Ban as unconstitutional, both on its face and as applied to him; to permanently enjoin Defendant from criminally

prosecuting Plaintiff or others for violations of the NOTA Ban; and to grant such other relief as the Court may deem just and proper. (Id. at 12). B. Procedural Background Plaintiff filed the Complaint in this case on April 15, 2021. (Dkt. #1). On July 26, 2021, Defendant filed a pre-motion letter requesting a conference to

2 The Court does not reach the merits of Plaintiff’s constitutional claims, but it notes for the sake of accuracy that the Contract Clause provides that “[n]o State shall … pass any … Law impairing the Obligation of Contracts.” U.S. Const., art. I, § 10 (emphasis added). The Contract Clause does not constrain federal legislation. See Ames v. Merrill Lynch, Pierce, Fenner & Smith, Inc., 567 F.2d 1174, 1179 (2d Cir. 1977) (“The obligation of contracts clause does not, of course, apply to the federal government[.]”). Further, Plaintiff brings his “right to privacy” claim under the Due Process Clause of the Fourteenth Amendment. (Compl. ¶ 44). That amendment similarly provides that “[n]o state shall … deprive any person of life, liberty, or property, without due process of law[.]”. U.S. Const. amend. XIV, § 1 (emphasis added). As Plaintiff is suing to enjoin a federal officer from enforcing a federal statute, his claim would properly be brought under the Due Process Clause of the Fifth Amendment. U.S. Const. amend. V (“No person shall … be deprived of life, liberty, or property, without due process of law[.]”). discuss his intention to file a motion to dismiss. (Dkt. #10). Plaintiff filed a response to Defendant’s pre-motion letter on August 5, 2021. (Dkt. #13). On August 13, 2021, the Court held a conference at which it set a deadline for

Plaintiff to amend his Complaint, as well as a briefing schedule for Defendant’s anticipated motion to dismiss. (See Minute Entry for Aug. 13, 2021). On September 7, 2021, having been advised that Plaintiff did not intend to amend his Complaint, the Court issued an Order confirming the briefing schedule for Defendant’s motion. (Dkt. #14). On October 4, 2021, Defendant filed his motion to dismiss under various subsections of Federal Rule of Civil Procedure 12(b), arguing in particular that Plaintiff’s complaint should be dismissed under Rule 12(b)(1) for lack of Article

III standing, under Rule 12(b)(3) for improper venue, and under Rule 12(b)(6) for failure to state a claim. (Dkt. #17-18). Plaintiff filed his opposition brief on November 4, 2021. (Dkt. #19). Defendant filed a reply memorandum of law in further support of his motion to dismiss on November 18, 2021. (Dkt. #20). Accordingly, the motion is fully briefed and ripe for the Court’s consideration. DISCUSSION A. The Court Grants Defendant’s Motion to Dismiss Under Rule 12(b)(1) 1. Applicable Law In all matters, the Court’s authority to exercise jurisdiction is constitutionally limited to actual cases and controversies. See U.S. Const., art.

III, § 2, cl. 1.; Am. Civ. Liberties Union v. Clapper, 785 F.3d 787, 800 (2d Cir. 2015) (“[N]o principle is more fundamental to the judiciary’s proper role in our system of government than the constitutional limitation of federal-court jurisdiction to actual cases or controversies.” (quoting Clapper v. Amnesty Int’l USA, 568 U.S. 398, 408 (2013))). This jurisdictional limitation requires, among

other things, that a party have standing to pursue his claims. See Spokeo, Inc. v. Robins, 578 U.S. 330

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McCarthy v. Dun & Bradstreet Corp.
482 F.3d 184 (Second Circuit, 2007)
Steffel v. Thompson
415 U.S. 452 (Supreme Court, 1974)
Babbitt v. United Farm Workers National Union
442 U.S. 289 (Supreme Court, 1979)
Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
MedImmune, Inc. v. Genentech, Inc.
549 U.S. 118 (Supreme Court, 2007)
Carver v. City of New York
621 F.3d 221 (Second Circuit, 2010)
Natalia Makarova v. United States
201 F.3d 110 (Second Circuit, 2000)
Clapper v. Amnesty International USA
133 S. Ct. 1138 (Supreme Court, 2013)
Kassner v. 2nd Avenue Delicatessen Inc.
496 F.3d 229 (Second Circuit, 2007)
Norex Petroleum Ltd. v. Access Industries, Inc.
540 F. Supp. 2d 438 (S.D. New York, 2007)
Cornwell v. Credit Suisse Group
666 F. Supp. 2d 381 (S.D. New York, 2009)
Maxim Group LLC v. Life Partners Holdings, Inc.
690 F. Supp. 2d 293 (S.D. New York, 2010)
Knife Rights, Inc. v. Vance
802 F.3d 377 (Second Circuit, 2015)
Spokeo, Inc. v. Robins
578 U.S. 330 (Supreme Court, 2016)
Broidy Capital v. Benomar
944 F.3d 436 (Second Circuit, 2019)
SM Kids, LLC v. Google LLC
963 F.3d 206 (Second Circuit, 2020)
Carney v. Adams
592 U.S. 53 (Supreme Court, 2020)
Harty v. West Point Realty, Inc.
28 F.4th 435 (Second Circuit, 2022)

Cite This Page — Counsel Stack

Bluebook (online)
Bellocchio v. Garland, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bellocchio-v-garland-nysd-2022.